Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -77.92% is 62% below its 5-year average of -48.15%, near the low end of its 5-year range (-77.92%–-19.13%).
As of the fiscal period ended Sunday, May 31, 2026. 34.93% below its 12-month average of -57.75%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-05-31): -77.92%.
RETURN ON INVESTED CAPITAL (ROIC)
-77.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-57.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-54.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-48.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-34.93%
CURRENT VS 3Y AVG
-44.24%
CURRENT VS 5Y AVG
-61.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-118.51%
vs the sector median at left
Nurix Therapeutics, Inc.
Market Cap
$2.35B
Return on Invested Capital (ROIC)
-77.92%
TTM Avg
-57.75%
3Y Avg
-54.02%
5Y Avg
-48.15%
Market Cap
$2.34B
Return on Invested Capital (ROIC)
12.75%
TTM Avg
12.12%
3Y Avg
12.86%
5Y Avg
10.67%
Market Cap
$2.36B
Return on Invested Capital (ROIC)
27.60%
TTM Avg
29.86%
3Y Avg
13.68%
5Y Avg
-0.60%
Market Cap
$2.37B
Return on Invested Capital (ROIC)
-38.21%
TTM Avg
-29.01%
3Y Avg
-27.76%
5Y Avg
-29.57%
Market Cap
$2.38B
Return on Invested Capital (ROIC)
-4.62%
TTM Avg
-19.11%
3Y Avg
-45.14%
5Y Avg
-60.93%
Market Cap
$2.30B
Return on Invested Capital (ROIC)
46.99%
TTM Avg
-39.61%
3Y Avg
-45.77%
5Y Avg
-48.25%
Market Cap
$2.28B
Return on Invested Capital (ROIC)
14.96%
TTM Avg
15.56%
3Y Avg
18.20%
5Y Avg
16.63%
Market Cap
$2.43B
Return on Invested Capital (ROIC)
-49.78%
TTM Avg
-43.13%
3Y Avg
-47.40%
5Y Avg
-42.10%
Market Cap
$2.24B
Return on Invested Capital (ROIC)
-26.95%
TTM Avg
-26.95%
3Y Avg
-26.95%
5Y Avg
-26.95%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | $2.35B | -77.92% | -57.75% | -54.02% | -48.15% |
| UFP Technologies, Inc. (UFPT)vs › | $2.34B | 12.75% | 12.12% | 12.86% | 10.67% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 27.60% | 29.86% | 13.68% | -0.60% |
| Disc Medicine, Inc. (IRON)vs › | $2.37B | -38.21% | -29.01% | -27.76% | -29.57% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.38B | -4.62% | -19.11% | -45.14% | -60.93% |
| Liquidia Corporation (LQDA)vs › | $2.30B | 46.99% | -39.61% | -45.77% | -48.25% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 14.96% | 15.56% | 18.20% | 16.63% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | -49.78% | -43.13% | -47.40% | -42.10% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.24B | -26.95% | -26.95% | -26.95% | -26.95% |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.49B | -10.24% | 1.21% | 1.35% | 3.39% |
ROIC
-77.9%
ROE
-84.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-05-31 | -77.92% |
| 2026-02-28 | -57.97% |
| 2025-11-30 | -47.48% |
| 2025-08-31 | -60.72% |
| 2025-05-31 | -44.67% |
| 2025-02-28 | -43.93% |
| 2024-11-30 | -37.15% |
| 2024-08-31 | -45.33% |
| 2024-05-31 | -40.87% |
| 2024-02-29 | -67.71% |
| 2023-11-30 | -56.16% |
| 2023-08-31 | -64.21% |
| 2023-05-31 | -58.15% |
| 2023-02-28 | -59.22% |
| 2022-11-30 | -52.29% |
| 2022-08-31 | -43.57% |
| 2022-05-31 | -47.51% |
| 2022-02-28 | -36.09% |
| 2021-11-30 | -28.45% |
| 2021-08-31 | -22.59% |
| 2021-05-31 | -19.13% |
| 2021-02-28 | -22.07% |
| 2020-11-30 | -18.47% |
| 2020-08-31 | -15.78% |
| 2020-05-31 | -23.46% |
| 2020-02-29 | -54.32% |
| 2019-11-30 | -79.67% |
